The interaction analysis between CD74 and other variables in the NSCLC cohort and LUAD cohort showed that the high expression of CD74 was a protective factor for OS, and there was no statistically significant difference in the interaction test of each variable (p > 0.05). Here, CD74 is linked to non-small cell lung carcinoma.